A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Expert Rev Vaccines. 2010;9(5):497-502. Thus, parents and caregivers should be reassured based on these data that vaccines will not overwhelm or weaken the infant immune system. The schedule of ...

Uncertain access The FDA's decision makes lenacapavir available today in the U.S., which sees about 31,000 of the 1.3 million new HIV infections each year worldwide.

New Vaccine Advisors Lack Vaccine Publications The eight new members appointed by Kennedy to the CDC's Advisory Committee on Immunization Practices have little experience with vaccine science ...

It was only in February 2024 that Valneva monetized a PRV obtained from the FDA approval of the U.S.’s first approved chikungunya vaccine, Ixchiq, for $103 million.

Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on two additional roles that will make the vocal critic of past agency practices ...

FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.

Between 2018 and 2023, tianeptine-related calls to US poison control centers skyrocketed 525% ...

FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.